TissueLabs raised €739k in a Pre-Seed round in Mar 2024. The company is based in Manno, Switzerland. Investors in the round: Mergus Ventures, MIT Angels. Data as of 7 Aug 2026.
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
This is the company's only recorded round.